Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
05/07/1998 | WO1998018826A2 Anti-ccr5 antibodies and methods of use therefor |
05/07/1998 | WO1998018825A1 Anti-p53 single-chain antibody fragments and their uses |
05/07/1998 | WO1998018824A1 Human tumor necrosis factor receptor-like 2 |
05/07/1998 | WO1998018820A1 Methods and compositions for ricin fusion protein immunotoxins to treat cancer and autoimmune disease |
05/07/1998 | WO1998018809A1 Targeted cytolysis of cancer cells |
05/07/1998 | WO1998018489A1 Enhancement of tumor cell chemosensitivity and radiosensitivity using single chain intracellular antibodies |
05/07/1998 | WO1998018488A1 Detection of antigens via oligonucleotide antibody conjugates |
05/07/1998 | WO1998018487A1 Prophylactic/remedial agent |
05/07/1998 | WO1998006841A3 Two human nsp-like proteins |
05/07/1998 | WO1998006248A3 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH α4β7 INTEGRIN |
05/07/1998 | WO1998002558A3 Chimeric receptors for jak-stat signal transduction |
05/07/1998 | WO1997044461A3 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
05/07/1998 | DE19645559A1 Pharmazeutische Antigen-/Antikörperpräparation Pharmaceutical antigen / antibody preparation |
05/07/1998 | CA2665133A1 Neutrokine .alpha. |
05/07/1998 | CA2271720A1 Streptococcus pneumoniae polynucleotides and sequences |
05/07/1998 | CA2270117A1 Process for producing tumoricide t-lymphocytes |
05/07/1998 | CA2269738A1 Targeted cytolysis of cancer cells |
05/07/1998 | CA2269663A1 Streptococcus pneumoniae antigens and vaccines |
05/07/1998 | CA2268750A1 Human p2x purinoreceptor |
05/06/1998 | EP0839915A1 Secretory immunoglobulin A as a mucosal vaccine delivery system |
05/06/1998 | EP0839910A2 Spo-rel, a Staphylococcus relA/spot homologue |
05/06/1998 | EP0839908A2 A novel human ETS family member, ELF3 |
05/06/1998 | EP0839831A2 Single chain gonadotropin |
05/06/1998 | EP0839536A1 Methods and compositions for promoting immunopotentiation |
05/06/1998 | EP0839208A1 A method for promoting enzyme diversity |
05/06/1998 | EP0839196A2 Human ctla-8 and uses of ctla-8-related proteins |
05/06/1998 | EP0839195A1 Nucleotide and peptide sequences for treating myasthenia |
05/06/1998 | EP0839183A1 Immortalized epithelial tumor cell |
05/06/1998 | EP0817849A4 Genetic sequences conferring nematode resistance in plants and uses therefor |
05/06/1998 | EP0733214B1 Dense microsphere components derived from mammalian brain tissue and antibodies thereto |
05/06/1998 | EP0673418B1 Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications |
05/06/1998 | CN1181111A Phycomilisomes, derivatives and uses therefor |
05/06/1998 | CN1181020A Non-toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation mthod therefor and pharmaceutical compositions containing same |
05/06/1998 | CN1180711A Thioether conjugates |
05/05/1998 | US5747654 Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
05/05/1998 | US5747653 Vaccination against infection caused by neisseria and purified with protein antigens complexes |
05/05/1998 | US5747652 Antibody to smooth muscle myosin heavy chains |
05/05/1998 | US5747651 Antibodies and hermatopoietic systems |
05/05/1998 | US5747650 Antibodies for proteins |
05/05/1998 | US5747643 Antibodies and peptides for antitumor agents |
05/05/1998 | US5747337 Factor VIII coagulant polypeptides and monoclonal antibodies to them |
05/05/1998 | US5747334 Random peptide library |
05/05/1998 | US5747319 Human mRNA editing enzyme |
05/05/1998 | US5747318 Mitogen activated c-Fos regulating kinase, FRK |
05/05/1998 | US5747315 DNA encoding aspartyl tRNA synthetase from Streptococcus pneumoniae |
05/05/1998 | US5747314 Nucleotides and genetic vectors |
05/05/1998 | US5747313 DNA encoding histidyl tRNA synthetase from Streptococcus pneumoniae |
05/05/1998 | US5747296 Polypeptides for genetic engineering |
05/05/1998 | US5747294 Antibody formed by hybridomas produced using cells from animal immunized with borrelia burgdorferi |
05/05/1998 | US5747293 Monoclonal antibodies and peptides |
05/05/1998 | US5747286 Polynucleotides encoding a transcriptional response regulator of Streptococcus pneumoniae |
05/05/1998 | US5747283 Polynucleotides, dna codes and antibodies for medical diagnosis and treatment of antiinflammatory conditions and anthelmintics |
05/05/1998 | US5747274 Method and device for diagnosing and distinguishing chest pain in early onset thereof |
05/05/1998 | US5747273 Immunoassay of total insulin-like growth factor binding protein-1 |
05/05/1998 | US5747269 Determination of peptide motifs on MHC molecules |
05/05/1998 | US5747267 Method for identifying a G protein coupled glutamate receptor agonist and antagonist |
05/05/1998 | US5747250 Probe for tumour diagnostics or tumour therapy |
05/05/1998 | US5747048 Antigrowth agents agents for cancer cell |
05/05/1998 | US5747046 Vaccine containing a protein complex form Haemonchus contortus |
05/05/1998 | US5747044 Hepatitis delta diagnostics and vaccines |
05/05/1998 | US5747037 Monoclonal antibodies bound to epitopes secreted by hybridomas |
05/05/1998 | US5747036 Methods and compositions for detecting and treating a subset of human patients having an autoimmune disease |
05/05/1998 | US5747035 Polypeptides with increased half-life for use in treating disorders involving the LFA-1 receptor |
05/05/1998 | US5747034 Methods and materials for the induction of T cell anergy |
05/05/1998 | US5747032 Monoclonal antibody to human granulocyte macrophage colony stimulating factor |
05/05/1998 | US5747031 Process for isolating immunoglobulins in whey |
05/05/1998 | US5747024 Vaccine adjuvant comprising interleukin-15 |
05/05/1998 | US5746996 Thiolation of peptides for radionuclide-based radiodetection and radiotherapy |
05/05/1998 | CA2115171C Monoclonal antibodies to human pulmonary surfactant apoprotein d and use thereof |
05/05/1998 | CA1339858C Human monoclonal antibodies specific for gp120 and gp41 and hybridomas for their production |
05/05/1998 | CA1339857C Monoclonal antibodies to gp120 which neutraleze hiv-1 |
05/05/1998 | CA1339853C Sf-25 colon adenocarcinoma antigen, and antibodies which recognize thisantigen |
05/03/1998 | CA2224920A1 Immunoassay for the detection and quantitation of toxins causing paralytic shellfish poisoning |
04/30/1998 | WO1998017826A1 Mitochondrial dna mutations that segregate with late onset diabetes mellitus |
04/30/1998 | WO1998017799A1 Immunotherapy and improved vaccines |
04/30/1998 | WO1998017798A1 Placental-derived prostate growth factors |
04/30/1998 | WO1998017797A1 ANTI-ErbB2 ANTIBODIES |
04/30/1998 | WO1998017796A2 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit |
04/30/1998 | WO1998017795A1 Nucleic acid encoding ds-cam proteins and products related thereto |
04/30/1998 | WO1998017794A1 Human eosinophil-derived basic protein |
04/30/1998 | WO1998017792A1 Binding molecules and computer-based methods of increasing the binding affinity thereof |
04/30/1998 | WO1998017786A1 Heat inactivation of viruses in antibody preparations |
04/30/1998 | WO1998017779A1 NOVEL FabH |
04/30/1998 | WO1998017691A1 Monoclonal antibodies against the ypydvpdya epitope, process for producing the same and their use |
04/30/1998 | WO1998017688A1 Osteometrin related peptides and nucleic acids and diagnosis and therapies using them |
04/30/1998 | WO1998017323A1 Improved vaccines |
04/30/1998 | WO1998017314A1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy |
04/30/1998 | WO1998017313A2 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases |
04/30/1998 | WO1998017312A1 Sepsis remedy comprising anti-il-8 antibody as active ingredient |
04/30/1998 | WO1998017301A1 Peptides for inhibiting retroviruses |
04/30/1998 | WO1998017300A1 Mucin-mediated immunomodulation |
04/30/1998 | WO1998017272A1 Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents |
04/30/1998 | WO1998017116A1 Targeted cytotoxic cells |
04/30/1998 | WO1998011225A3 A novel haemopoietin receptor and genetic sequences encoding same |
04/30/1998 | WO1998008098A3 Assaying D-amino acids in body fluids |
04/30/1998 | WO1998002545A3 Compositions and methods for plant pathogen resistance |
04/30/1998 | DE19644501A1 GABA¶A¶-Rezeptoruntereinheit epsilon-verwandtes Protein GABA¶A¶ receptor epsilon subunit-related protein |
04/30/1998 | CA2751712A1 Immunotherapy and improved vaccines |
04/30/1998 | CA2745736A1 Immunotherapy and improved vaccines |
04/30/1998 | CA2272601A1 Peptides for inhibiting retroviruses |